Exagen inc. reports strong fourth quarter and full-year 2023 results

Carlsbad, calif., march 18, 2024 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year ended december 31, 2023.
XGN Ratings Summary
XGN Quant Ranking